Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116546623 | 11654662 | 3 | F | 2005 | 20160711 | 20151023 | 20160728 | PER | US-PFIZER INC-2015337220 | PFIZER | 39.00 | YR | M | Y | 79.00000 | KG | 20160728 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116546623 | 11654662 | 1 | PS | ATORVASTATIN CALCIUM. | ATORVASTATIN CALCIUM | 1 | Oral | 10 MG, 1X/DAY | Y | 20702 | 10 | MG | FILM-COATED TABLET | QD | |||||
| 116546623 | 11654662 | 2 | C | CLOMIPRAMINE | CLOMIPRAMINE | 1 | 50 MG, DAILY | 0 | 50 | MG | |||||||||
| 116546623 | 11654662 | 3 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 500 MG, UNK | 0 | 500 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 116546623 | 11654662 | 1 | Blood cholesterol increased |
| 116546623 | 11654662 | 2 | Anxiety |
| 116546623 | 11654662 | 3 | Type 2 diabetes mellitus |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 116546623 | 11654662 | Arthralgia | |
| 116546623 | 11654662 | Myalgia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 116546623 | 11654662 | 2 | 1993 | 0 |